ArticleCurrent genomics2025

CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer.

Xingyu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.